Ligandal

United States
Silver Bay, Minnesota, United States, 11201

Company profile

Ligandal company profile

Ligandal's mission is to create precision delivery platform to cure and treat disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design of diagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to indications in hematology, immuno-oncology, and infectious disease.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2014-01-01, Year

Headquarters

Postal code
11201
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
7
Total equity funding
$4.6M
Last funding
Seed / $1.8M / 2019-02-01
Last equity funding
Seed / $1.8M
Investors
23
Founders
2
Articles
14

Founders and investors

Founders

Andre WatsonChristian Foster

Investors

OODAPropel(X)Social CapitalSocial Impact CapitalTechammer